UG 100 Sequencing Platform Will Expand Oncology Test Offerings
NeoGenomics and Ultima Genomics have partnered to use the UG 100 sequencing platform to advance precision oncology diagnostics.
NeoGenomics and Ultima Genomics have partnered to use the UG 100 sequencing platform to advance precision oncology diagnostics.
While serving the region, Doylestown Health has a small clinical laboratory. To better serve its community, it added NGS in 2023.Â
Reducing the incidence of healthcare-associated infections, and the antimicrobial resistance they can trigger, is critical for patient care.
Whole genome sequencing has improved care for some children with cancer in England and can potentially replace multiple standard tests.
Read MoreA new genotyping test using cerebrospinal fluid can rapidly diagnose brain cancers, reducing the need for invasive biopsies.
Read MoreFoundation Medicine launched a tissue-based RNA sequencing test in the U.S. for the detection of cancer-related fusions across 318 genes.Â
Read MoreJona announced a new distribution partnership where practitioners can order Jona kits, the company’s AI-powered gut microbiome profile test.
Read MoreResearchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read MoreThe collaboration seeks to demonstrate the value of WGS as a first-line genetic test for postnatal diagnosis of developmental delay disorders.
Read MoreResearchers developed a platform for integrating DNA and RNA data from single-cell sequencing with improved speed and precision.
Read MoreResearchers analyzed data from children who suffered from syndromic conditions and found a high incidence of overlapping genetic alterations.
Read MoreThe new suite of high-quality adapters, universal blockers, and library amplification primer mixes are designed for the AVITI System.
Read MoreThe system features full 24/7 run automation, flexibility for smaller and faster runs, high accuracy for germline applications, and more.
Read MoreFindings from NGS suggest that revising cancer care guidelines could allow many more patients to benefit from immunotherapy treatment.
Read MoreGenomenon, a genomic intelligence company, has launched Genomenon Curate-Pro, a rapid on-demand...
Read MoreIllumina’s Global Health Access Initiative will support access to pathogen sequencing tools for public health in lower income countries.
Read MoreSequentify announced Stanford will be using the company’s NGS targeted panels for acute myeloid leukemia (AML) somatic mutation detection.
Read MoreCentogene announced the expansion of MOx, the company’s multiomic diagnostic portfolio, now incorporating transcriptomic analysis.
Read More